To gain mechanistic insights into the clinical relevance of p‐TFCP2L1 in bladder carcinogenesis, we first compared the endogenous expression levels of TFCP2L1 and CDK1 between primary human bladder epithelial cells (HBlEpCs) and BC cell lines such as J82 and T24. This evidence concerns the gene CDK1 and breast cancer.